tiprankstipranks
Trending News
More News >
Sumitomo Seika Chemicals Co., Ltd. (JP:4008)
:4008
Japanese Market
Advertisement

Sumitomo Seika Chemicals Co., Ltd. (4008) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4008

Sumitomo Seika Chemicals Co., Ltd.

(4008)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
¥5,810.00
▲(8.80% Upside)
The stock's overall score is driven by solid financial performance and attractive valuation. While technical indicators show strong momentum, overbought signals suggest caution. The lack of earnings call data and corporate events limits additional insights.
Positive Factors
Revenue Growth
Consistent revenue growth indicates expanding market reach and strong demand for its products, enhancing long-term business stability.
Stable Gross Profit Margins
Stable gross profit margins suggest efficient cost control, which supports profitability and competitive pricing strategies over time.
Financial Stability
A strong equity base and favorable equity ratio provide financial stability, allowing for strategic investments and resilience against economic fluctuations.
Negative Factors
Fluctuating Net Profit Margins
Fluctuating net profit margins can signal instability in profitability, which may affect investor confidence and long-term financial planning.
Variability in Free Cash Flow
Volatile free cash flow can hinder the company's ability to fund operations and growth initiatives, impacting long-term sustainability.
Inconsistent Return on Equity
Inconsistent return on equity suggests challenges in generating profit from shareholders' investments, potentially affecting shareholder value.

Sumitomo Seika Chemicals Co., Ltd. (4008) vs. iShares MSCI Japan ETF (EWJ)

Sumitomo Seika Chemicals Co., Ltd. Business Overview & Revenue Model

Company DescriptionSumitomo Seika Chemicals Co., Ltd. (4008) is a Japanese chemical company specializing in the production and sale of a diverse range of chemical products. The company operates in several sectors, including specialty chemicals, plastics, and electronic materials. Core products include high-performance polymers, fine chemicals, and additives used in various industries such as automotive, electronics, and pharmaceuticals.
How the Company Makes MoneySumitomo Seika Chemicals generates revenue through the manufacturing and sale of its chemical products across multiple markets. Key revenue streams include the sale of specialty chemicals and materials, which cater to specific industries like electronics and automotive. The company also benefits from long-term partnerships with major clients and manufacturers, which provide a steady demand for its products. Additionally, Sumitomo Seika engages in research and development to innovate and expand its product offerings, thereby enhancing its market competitiveness and driving sales growth.

Sumitomo Seika Chemicals Co., Ltd. Financial Statement Overview

Summary
Sumitomo Seika Chemicals Co., Ltd. shows consistent revenue growth and stable gross profit margins, indicating effective cost management. However, fluctuating net profit margins and variability in free cash flow suggest areas for improvement in profitability consistency and cash management.
Income Statement
75
Positive
The company demonstrates a consistent revenue growth trend with a notable increase from 2020 to 2025. Gross profit margins have remained stable, reflecting effective cost management. However, net profit margins have fluctuated, indicating potential volatility in bottom-line results. EBIT and EBITDA margins show a solid performance, suggesting strong operating efficiency.
Balance Sheet
70
Positive
The balance sheet is characterized by a robust equity base, with a favorable equity ratio indicating financial stability. The debt-to-equity ratio is manageable, suggesting controlled leverage. However, the return on equity has shown variability, which may indicate inconsistent profitability relative to shareholders’ equity.
Cash Flow
65
Positive
Operating cash flow has been strong, but free cash flow exhibited significant volatility, particularly a downturn in the latest period. The operating cash flow to net income ratio is healthy, yet the free cash flow to net income ratio highlights potential concerns in cash generation relative to profitability.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue146.24B147.57B142.99B143.04B115.58B103.25B
Gross Profit30.38B30.68B28.01B30.14B26.15B25.18B
EBITDA10.96B14.35B14.87B15.55B13.59B15.38B
Net Income4.49B5.96B6.17B8.59B5.89B7.12B
Balance Sheet
Total Assets141.32B141.53B136.31B126.65B121.27B107.83B
Cash, Cash Equivalents and Short-Term Investments18.93B16.86B21.66B23.55B29.25B25.66B
Total Debt22.29B18.86B11.57B12.62B14.55B14.09B
Total Liabilities47.05B47.22B41.25B39.99B39.37B32.34B
Stockholders Equity94.26B94.31B95.05B86.66B78.73B72.79B
Cash Flow
Free Cash Flow0.00-5.98B2.04B-128.00M5.39B13.18B
Operating Cash Flow0.0013.68B12.01B6.70B9.02B16.25B
Investing Cash Flow0.00-20.91B-10.37B-5.94B-4.32B-2.23B
Financing Cash Flow0.003.19B-5.77B-8.30B-2.99B-3.26B

Sumitomo Seika Chemicals Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5340.00
Price Trends
50DMA
4868.64
Positive
100DMA
4653.80
Positive
200DMA
4615.85
Positive
Market Momentum
MACD
150.92
Negative
RSI
70.24
Negative
STOCH
76.92
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4008, the sentiment is Positive. The current price of 5340 is above the 20-day moving average (MA) of 5083.25, above the 50-day MA of 4868.64, and above the 200-day MA of 4615.85, indicating a bullish trend. The MACD of 150.92 indicates Negative momentum. The RSI at 70.24 is Negative, neither overbought nor oversold. The STOCH value of 76.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4008.

Sumitomo Seika Chemicals Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
¥64.28B13.153.33%3.03%28.27%
77
Outperform
¥86.29B17.2210.57%1.77%15.12%40.72%
76
Outperform
¥70.48B5.973.14%1.57%-33.97%
74
Outperform
¥106.40B7.644.71%1.16%167.89%
68
Neutral
¥65.88B14.083.77%-0.68%-9.93%
63
Neutral
¥97.82B17.141.25%47.56%49.58%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4008
Sumitomo Seika Chemicals Co., Ltd.
5,320.00
816.22
18.12%
JP:4187
Osaka Organic Chemical Industry Ltd.
3,955.00
1,353.71
52.04%
JP:4028
ISHIHARA SANGYO KAISHA, LTD.
2,809.00
1,433.19
104.17%
JP:4116
Dainichiseika Color & Chemicals Mfg.Co., Ltd.
4,005.00
1,264.25
46.13%
JP:4362
Nippon Fine Chemical Co., Ltd.
2,822.00
423.85
17.67%
JP:4369
Tri Chemical Laboratories Inc.
2,792.00
20.35
0.73%

Sumitomo Seika Chemicals Co., Ltd. Corporate Events

Sumitomo Seika Chemicals Corrects Financial Results for FY 2025
Nov 12, 2025

Sumitomo Seika Chemicals Co., Ltd. announced corrections to its previously released consolidated financial results for the year ended March 31, 2025, due to aggregation errors in the data. These corrections are crucial for maintaining accurate financial reporting and transparency, which can impact the company’s credibility and stakeholder trust.

The most recent analyst rating on (JP:4008) stock is a Buy with a Yen5423.00 price target. To see the full list of analyst forecasts on Sumitomo Seika Chemicals Co., Ltd. stock, see the JP:4008 Stock Forecast page.

Sumitomo Seika Announces Share Buyback Plan to Boost Capital Efficiency
Nov 12, 2025

Sumitomo Seika Chemicals Co., Ltd. has announced a decision by its Board of Directors to acquire up to 210,000 of its own shares, with a maximum expenditure of 1 billion yen, to improve capital efficiency and enhance shareholder returns. This acquisition, set to occur between November 13, 2025, and March 31, 2026, will not impact the company’s financial results for the fiscal year ending March 31, 2026.

The most recent analyst rating on (JP:4008) stock is a Buy with a Yen5423.00 price target. To see the full list of analyst forecasts on Sumitomo Seika Chemicals Co., Ltd. stock, see the JP:4008 Stock Forecast page.

Sumitomo Seika Chemicals Revises Financial Forecasts for FY 2026
Nov 12, 2025

Sumitomo Seika Chemicals Co., Ltd. has revised its full-year consolidated financial forecasts for the fiscal year ending March 31, 2026. While net sales remain unchanged, operating and ordinary profits are expected to increase due to lower raw material costs and a weaker yen against the Chinese yuan. However, profit attributable to owners is projected to decrease due to anticipated business restructuring costs and increased expenses related to customer discussions. The dividend forecast remains unchanged at 100 yen per share.

The most recent analyst rating on (JP:4008) stock is a Buy with a Yen5423.00 price target. To see the full list of analyst forecasts on Sumitomo Seika Chemicals Co., Ltd. stock, see the JP:4008 Stock Forecast page.

Sumitomo Seika Chemicals Reports Financial Results and Announces Treasury Share Acquisition
Nov 12, 2025

Sumitomo Seika Chemicals reported its consolidated financial results for the six months ending September 30, 2025, showing a slight decline in net sales by 1.7% compared to the previous year. Despite this, the company achieved a significant increase in operating profit by 19.9% and ordinary profit by 18.0%, indicating improved operational efficiency. The company also announced plans to acquire treasury shares, which is expected to impact the basic earnings per share forecast for the fiscal year ending March 31, 2026.

The most recent analyst rating on (JP:4008) stock is a Buy with a Yen5423.00 price target. To see the full list of analyst forecasts on Sumitomo Seika Chemicals Co., Ltd. stock, see the JP:4008 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 18, 2025